Generare

We are looking for a passionate microbiology intern to join the team early 2025! Link to the offer : https://lnkd.in/gedZ2quc Feel free to share if you know anyone 🙏

𝗦𝗮𝗺𝗽𝗹𝗲 microbes from the environment 𝗥𝗲𝘃𝗲𝗮𝗹 bioactive molecules at unprecedented speed and scale 𝗛𝗮𝗿𝗻𝗲𝘀𝘀 their potential for medicine and beyond More info: https://generare.bio/ Open positions: https://shorturl.at/nuTsh Credits: Units; Roman Weil; Tom Formont

The news is out! We’re thrilled to announce Generare has raised €5 million in Seed funding to take our drug discovery platform to the next level. Natural products hiding in bacteria are our best shot at finding the next generation of medicines – they’ve led to 500+ drugs already, and are 100x more likely than plants and chemicals to get approved. Yet finding them remains a significant global challenge. At Generare, we’re building a platform that is not only reopening this critical avenue of drug discovery, but can do so at scale; leveraging decades of research from our award-winning team. We’ve already identified 100+ previously unknown molecules (and counting); we’ve signed our first pilot with AUROBAC THERAPEUTICS; and been recognised by a number of industry bodies over the past year alone.  Today’s announcement of our Seed funding is the icing on the cake 🎂   Not only because it validates our mission and ambition, but because our new investors – Teampact.ventures, Galion.exe, VIVES Partners, SynBioVen, Saras Capital, Better Angle – bring a wealth of expertise that will now help us take this mission forward. Thanks to Natasha Lomas for covering our journey on TechCrunch, and to all of our team and partners that have been a part of this journey so far! We’re excited to take things to the next level in the weeks, months and years to come. Read the full announcement here : https://lnkd.in/exxfpFiA #biotech #innovation #drugdiscovery #naturalproducts

I am thrilled to share a new milestone in Generare's journey! We have closed a €5M funding round, led by Teampact.ventures, Galion.exe, and VIVES Partners, to scale up our platform for discovering natural molecules from microorganisms. Nature holds treasures in the form of natural molecules, selected by evolution over millions of years. Thanks to Generare's technology, we systematically explore this wealth to transform the way we develop the medicines of tomorrow. I am proud and excited to be on this adventure with Vincent Libis, Baudoin Delépine, Héloïse G., Oriane Monet, Nadège Guinot, Baptiste F., Bismarck Olympio, Humbeline Paupelin (Vaucelle), GUIDO RODRIGO, Hugo Boutonnet, Anne-Camille Renaudeau, Charlotte Thiola, and Grace K. For the past two years, we have been working together to scale up this approach, inspired by Vincent's brilliant research. A big thank you to everyone who is a part of this adventure! Thanks Natasha Lomas of TechCrunch for covering our journey! https://tcrn.ch/3ZS9nr1

Très fier de mon associé Vincent Libis, lauréat du Prix des innovateurs de la Région Ile de France, et des travaux menés en collaboration par les équipes de l'INSERM et Generare pour accélérer la découverte de nouveaux médicaments issus de microorganismes, et notamment de nouveaux antibiotiques dont nous manquons cruellement. #antibioresistance #startup #iledefrance PS : Bravo aux équipes de la Région et Marie Morel pour la vidéo qui est très chouette !

Generare is proud to be part of this year's selection of amazing frontier science startups of the i-lab Grant from Gouvernement, ADEME and Bpifrance Congrats to Nūmi, Orakl Oncology, Linium Biochemicals and all the other amazing projects who were awarded.

Join Generare, where synthetic biology meets computational methods to harness the ingenuity of nature. Be part of our mission to create a discovery engine for Natural Products – first-in-class drugs encoded in the DNA of microbes from the soil.

The whole Generare team is excited to contribute its discovery platform to support AUROBAC THERAPEUTICS's mission in addressing a critical unmet medical need. We are inspired to work with such a clear-sighted team, dedicated to fighting serious bacterial infections.

Generare is thrilled to announce that we will be at VivaTech 2024! Join us at the Région Ile de France booth for the DIM BioConvS Session. Our CEO, Guillaume Vandenesch, will present our revolutionary discovery platform on Friday, May 24, 2024, at 3:15 PM. BioconvS, short for BioConvergence for Health, is a major research initiative (DIM) funded by the Île-de-France region, aiming to advance synthetic biology, biotherapy, and bioproduction. Discover how Generare is pioneering the search for first-in-class drugs hidden in the DNA of soil bacteria. See you there! #VivaTech #Generare #BioConvergence #HealthInnovation #IledeFrance #VivaTech2024

INCATEurope has published the pitches from the 8th AMR Conference. Rewatch Guillaume Vandenesch's intervention using the link below. https://lnkd.in/gqkFByWv